Hyperbaric oxygen: a novel technology for modulating myocardial schemia-reperfusion via a single drug. | Canada Hyperbarics Skip to main content
Clinical Study Advances in therapy 2006

Hyperbaric oxygen: a novel technology for modulating myocardial schemia-reperfusion via a single drug.

Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S — Advances in therapy, 2006

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

This article reviewed pertinent developments regarding hyperbaric oxygen (HBO) and myocardial ischaemia-reperfusion injury (IRI).

What They Found

The review highlighted that hyperbaric oxygen (HBO) has demonstrated cellular and clinical benefits, particularly in ischaemic reperfusion injury (IRI). It noted that HBO has recently been shown to be a useful adjunct in several models of IRI, including myocardial infarction.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patient populations.

Study Limitations

The article noted that the precise mechanisms by which hyperbaric oxygen exerts its beneficial effects in myocardial ischaemia-reperfusion injury remain to be fully understood.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Cardiac
Source Pubmed
PubMed ID 17050495
Year Published 2006
Journal Advances in therapy
MeSH Terms Animals; Clinical Trials as Topic; Humans; Hyperbaric Oxygenation; Myocardial Reperfusion Injury

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology